Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd > Trial update-sites added

<< Previous

Bullboard Posts

Next >>

Comment by 1ottrunneron Jul 13, 2021 8:44am

145 Views

Post# 33534925

RE:RE:Trial update-sites added

Hopefully these sites have been active for a few weeks and they are simply updating late.

I've seen posts on the FB group proclaiming that no new sites is an obvious positive sign, I wonder what sign it is now?

The trial stipend must be pitiful. Imagine if investors had funded this trial for 20 million dollars, that's right, we did!

The trial must have positive data or I'm certain they would have put it to rest.

TheTerminator1 wrote: WOW.....that's 7 new clinical sites

I am impressed !

1ottrunner wrote: https://clinicaltrials.gov/ct2/history/NCT04504734?A=27&B=28&C=merged#StudyPageTop